HCPCS J2356
Injection, tezepelumab-ekko, 1 mg (CMS descriptor)
Drugs Drug code
Trend
Medicare payment on the code
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2022–2024.
Billers
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2022–2024.
| observed | calculated | calculated | calculated | calculated | calculated | reported | |
|---|---|---|---|---|---|---|---|
| 2024 | 206 | $49,939,375 | +127% | 3,539,998 | 13,860 | 39,795 | 0.00 |
| 2023 | 113 | $21,999,025 | +847% | 1,560,505 | 12,180 | 31,795 | 0.00 |
| 2022 | 21 | $2,322,300 | not in the 2021 file | 166,747 | 6,930 | 14,070 |
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2022–2024.
By state
No state has a reportable line for J2356 in 2022.
Top metro areas
No metro area has a reportable line for J2356 in 2022.
Specialties billing J2356 nationally
Not listed: 5 specialties with fewer than 11 billers (small cells).
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Provider-level lines (fewer than 11 beneficiaries suppressed by CMS); specialty is the provider type on claims. Data year 2022.
Top billers of J2356 nationally
Named top billers are a Pro figure, and Pro is not available to buy, so this list is not shown to any account. The counts and totals by state, metro area and specialty on this page are free.
Original Medicare Part B fee-for-service only; CMS suppresses provider lines with fewer than 11 beneficiaries. How these figures are computed · Limitations